Single-agent duloxetine ingestions

Human and Experimental Toxicology

Volumn 32, Issue 4, 2013, Pages 427-433

  Jacob, J ^a   Albert, D ^a   Heard, K ^a  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

Author keywords

AAPCC; clinical effects; Duloxetine; ingestion; NPDS

Indexed keywords

ACTIVATED CARBON; DULOXETINE;

ABDOMINAL PAIN; AGITATION; ARTICLE; ATAXIA; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM FUNCTION; CHILD; COMA; DELUSION; DEMOGRAPHY; DIAPHORESIS; DIZZINESS; DROWSINESS; DRUG EFFECT; DRUG EXPOSURE; DRUG INTOXICATION; FASCICULATION; FEVER; GASTROINTESTINAL DISEASE; GROUPS BY AGE; HALLUCINATION; HEALTH CARE FACILITY; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; INGESTION; IRRITABILITY; MAJOR CLINICAL STUDY; MUSCLE RIGIDITY; NAUSEA; NEUROLOGIC DISEASE; NYSTAGMUS; POISON CENTER; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SIDE EFFECT; TACHYCARDIA; TREMOR; VERTIGO; VOMITING;

ADULT; ANTIDEPRESSIVE AGENTS; CHILD; DIZZINESS; EATING; FEMALE; HUMANS; LETHARGY; MALE; MIDDLE AGED; NAUSEA; POISON CONTROL CENTERS; SLEEP STAGES; TACHYCARDIA; THIOPHENES; VOMITING; YOUNG ADULT;

EID: 84876722735     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112462726     Document Type: Article

References (22)

1. Brunton S, Wang F, Edwards SB, et al. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf. 2010 ; 33 (5). 393-407
2. Serra E. Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyalgia?. Nat Clin Pract Neurol. 2008 ; 4 (11). 594-595
3. Choy EH, Mease PJ, Kajdasz DK, et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol. 2009 ; 28 (9). 1035-1044
4. Bitter I, Filipovits D, Czobar P. Adverse reactions to duloxetine in depression. Expert Opin Drug Saf. 2011 ; 10 (6). 839-850
5. Raskin J, Wiltse CG, Dinkel JJ, et al. Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder. J Clin Psychopharmacol. 2008 ; 28 (1). 32-38
6. Mease PJ, Russell J, Kajdasz DK. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010 ; 39 (6). 454-464
7. Chappell AS, Littlejohn G, Kajdasz DK. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. Clin J Pain. 2009 ; 25 (5). 365-375
8. AAPCC. NPDS Annual Report Terminology. http://www.aapcc.org/dnn/ NewsandEvents/NewsMediaResources/NPDSAnnualReportTerminology.aspx(accessed February 15, 2012).
9. Brayden RM, MacLean WE, Bonfiglio JF, et al. Behavioral antecedents of pediatric poisonings. Clin Pediatr. 1993 ; 32 (1). 30-35
10. Dunkley EJ, Isbister GK, Sibbritt D, et al. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003 ; 96 (9). 635-642
11. Wedin GP, Oderda GM, Klein-Schwartz W, et al. Relative toxicity of cyclic antidepressants. Ann Emerg Med. 1986 ; 15 (7). 797-804
12. Starr P, Klein-Schwartz W, Spiller H, et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009 ; 27 (8). 911-915
13. Beuhler MC, Spiller HA, Sasser HC. The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. J Med Toxicol. 2010 ; 6 (1). 4-8
14. Isbister GK, Bowe SJ, Dawson A, et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004 ; 42 (3). 277-285
15. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM. 2003 ; 96 (5). 369-374
16. Yilmaz Z, Ceschi A, Rauber-Lüthy C, et al. Escitalopram causes fewer seizures in human overdose than citalopram. Clin Toxicol (Phila). 2010 ; 48 (3). 207-212
17. Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol. 2004 ; 42 (1). 67-71
18. Howell C, Wilson AD, Waring WS. Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. Br J Clin Pharmacol. 2007 ; 64 (2). 192-197
19. Catalano G, Catalano MC, Epstein MA, et al. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol. 2001 ; 24 (3). 158-162
20. Isbister GK, Balit CR.. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother. 2003 ; 37 ((7-8)). 999-1002
21. Hayes BD, Klein-Schwartz W, Clark RF, et al. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med. 2010 ; 39 (1). 44-48
22. Gelener P, Gorgulu U, Kutlu G, et al. Serotonin syndrome due to duloxetine. Clin Neuropharmacol. 2011 ; 34 (3). 127-128